Anna S Kreutzman

6PUBLICATIONS
44CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Feb 04, 2026
Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models.

Neja Sirc, Johannes Smolander, Anita N Kumari

|Jul 24, 2023
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen

|Jan 10, 2022
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma.

Moon Hee Lee, Petrus Järvinen, Harry Nísen

|Feb 10, 2020
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients.

Henna Kasanen, Micaela Hernberg, Siru Mäkelä

|Aug 21, 2019
Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line.

Anna Kreutzman, Bhagwan Yadav, Tim H Brummendorf

Pageof 1

Frequent Collaborators

6 joint publications

Satu Mustjoki

3 joint publications

Karita Peltonen

3 joint publications

Moon Hee Lee

3 joint publications

Petrus Järvinen